The ship-shaped formation on the mountain has long fascinated researchers (Picture: NoahsArkScans)
A site that some experts believe could hide the remains of Noah’s Ark has been found to feature cor
The teenage cyber gang claimed to have breached AstraZeneca in March (Picture: Getty)
A global drug company which pioneered the Covid vaccine has been victim of a cyber attack,Metro can reveal.
It may not be top of the list for any colonisation plans by Elon Musk, but has intrigued scientists studying it with the James Webb Space Telescope (JWST)
Prince Harry secretly travelled to Ukraine overnight (Picture: Reuters)
Prince Harry has made a direct appeal to Vladimir Putin to end the conflict and ‘choose a different course’ during surprise v
BARCELONA,Spain,Feb. 25,2025-- IIIF150,the imaginative ultra-thin rugged phone manufacture,announced their new flagship Raptor 5G which will be showcased in Barcelona,and different tests onsite to cha
Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.
NEW YORK,Feb. 25,2025-- BUYING SQUARE,operator of the next-generation digital wholesale platform Catalog Shop,unveiled its experiential brand showroom,VIBE TWLV,in Brooklyn,New York. The 4,270-square-
NINGBO,China,Feb. 26,2025-- Breaking new ground in solar innovation! Risen\'sHJT (Heterojunction Technology),when combined with aperovskitecell in a tandem structure,has achieved an impressive30.99% e
PARIS,Feb. 25,2025-- Little Artists Art Studio,is proud to share the historic debut of their young and rising talents at the prestigious Art Capital Paris: Le Salon des Artistes Français at the
HONG KONG,Feb. 25,2025-- On 21 February,Guo Guangchang,Chairman of Fosun International spoke at the 25th Annual Conference of Yabuli China Entrepreneurs Forum 2025,stating that private enterprises are
SHANGHAI,Feb. 23,2025-- BioCityBiopharma (BioCity) announced that its selective endothelin receptor type A (ETA) antagonist,SC0062,met the 12-week primary endpoint of a reduction in proteinuria in the
Sugemalimab is the world\'s first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. The GEMSTONE-303 study results support sugem
SHENZHEN,China,Feb. 25,2025--Pudu Robotics,a global leader in service robotics,is revolutionizing cleanliness standards at Ryugujo Spa Hotel Mikazuki Ryugutei in Japan,a renowned Japanese hot spring
